MCL1 and Miyoshi myopathy: In the present study, PRIMA-1Met downregulated Mcl-1 transcript and protein (Figure 4A, supplementary figure 1), and interestingly this effect was partially reversed by AMO-29a in MM.1S cells suggesting that PRIMA-1Met may also trigger MM cell death through miRNA-29a targeting Mcl-1.